Literature DB >> 2172988

Introduction of nerve growth factor (NGF) receptors into a medulloblastoma cell line results in expression of high- and low-affinity NGF receptors but not NGF-mediated differentiation.

S J Pleasure1, U R Reddy, G Venkatakrishnan, A K Roy, J Chen, A H Ross, J Q Trojanowski, D E Pleasure, V M Lee.   

Abstract

Expression of the cloned human nerve growth factor receptor (NGFR) cDNA in cell lines can generate both high- and low-affinity binding sites. Since the inability to respond appropriately to differentiation factors such as NGF may contribute to determining the malignant phenotype of neuroblastomas, we sought to determine whether the same is true of medulloblastomas. To generate a human central nervous system neuronal cell line that would respond to NGF, we infected the medulloblastoma cell line D283 MED with a defective retrovirus carrying the cDNA coding for the human NGFR. The resultant cells (MED-NGFR) expressed abundant low- and high-affinity NGFRs, and NGF treatment induced a rapid transient increase of c-fos mRNA in the NGFR-expressing cells but not in the parent line or in cells infected with virus lacking the cDNA insert. However, the MED-NGFR cells did not internalize the NGFR at high efficiency, nor did they differentiate in response to NGF. Three important conclusions emerge from this study: (i) internalization of NGFRs is not necessary for some early rapid transcriptional effects of NGF; (ii) an unknown factor(s) that cooperates with the cloned NGFR in allowing high-affinity NGF binding is found in a primitive central nervous system cell line; and (iii) NGFRs introduced into and expressed by D283 MED (i.e., MED-NGFR) cells are partially functional but are unable to induce differentiation in these primitive neuron-like tumor cells, implying that high-efficiency receptor-mediated endocytosis of NGF and its receptor may be a necessary step in the cascade of events leading to NGF-mediated differentiation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2172988      PMCID: PMC54983          DOI: 10.1073/pnas.87.21.8496

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Assaying binding of nerve growth factor to cell surface receptors.

Authors:  R D Vale; E M Shooter
Journal:  Methods Enzymol       Date:  1985       Impact factor: 1.600

Review 2.  Physiology of nerve growth factor.

Authors:  H Thoenen; Y A Barde
Journal:  Physiol Rev       Date:  1980-10       Impact factor: 37.312

3.  A single Mr approximately 103,000 125I-beta-nerve growth factor-affinity-labeled species represents both the low and high affinity forms of the nerve growth factor receptor.

Authors:  S H Green; L A Greene
Journal:  J Biol Chem       Date:  1986-11-15       Impact factor: 5.157

4.  Phenotypic analysis of four human medulloblastoma cell lines and transplantable xenografts.

Authors:  X M He; S X Skapek; C J Wikstrand; H S Friedman; J Q Trojanowski; J T Kemshead; H B Coakham; S H Bigner; D D Bigner
Journal:  J Neuropathol Exp Neurol       Date:  1989-01       Impact factor: 3.685

5.  Nerve growth factor receptor immunoreactivity is transiently associated with the subplate neurons of the mammalian cerebral cortex.

Authors:  K L Allendoerfer; D L Shelton; E M Shooter; C J Shatz
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

6.  An immunohistochemical study of the nerve growth factor receptor in developing rats.

Authors:  Q Yan; E M Johnson
Journal:  J Neurosci       Date:  1988-09       Impact factor: 6.167

7.  Association of 125I-nerve growth factor with PC12 pheochromocytoma cells. Evidence for internalization via high-affinity receptors only and for long-term regulation by nerve growth factor of both high- and low-affinity receptors.

Authors:  P Bernd; L A Greene
Journal:  J Biol Chem       Date:  1984-12-25       Impact factor: 5.157

8.  Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodies.

Authors:  A H Ross; P Grob; M Bothwell; D E Elder; C S Ernst; N Marano; B F Ghrist; C C Slemp; M Herlyn; B Atkinson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

9.  Nerve growth factor enhances the synthesis, phosphorylation, and metabolic stability of neurofilament proteins in PC12 cells.

Authors:  M H Lindenbaum; S Carbonetto; W E Mushynski
Journal:  J Biol Chem       Date:  1987-01-15       Impact factor: 5.157

10.  Studies on the expression of the beta nerve growth factor (NGF) gene in the central nervous system: level and regional distribution of NGF mRNA suggest that NGF functions as a trophic factor for several distinct populations of neurons.

Authors:  D L Shelton; L F Reichardt
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

View more
  18 in total

Review 1.  Identification of tyrosine kinase Trk as a nerve growth factor receptor.

Authors:  A H Ross
Journal:  Cell Regul       Date:  1991-09

2.  The low-affinity p75 nerve growth factor (NGF) receptor mediates NGF-induced tyrosine phosphorylation.

Authors:  M M Berg; D W Sternberg; B L Hempstead; M V Chao
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

3.  The trk tyrosine protein kinase mediates the mitogenic properties of nerve growth factor and neurotrophin-3.

Authors:  C Cordon-Cardo; P Tapley; S Q Jing; V Nanduri; E O'Rourke; F Lamballe; K Kovary; R Klein; K R Jones; L F Reichardt
Journal:  Cell       Date:  1991-07-12       Impact factor: 41.582

4.  Nerve growth factor receptor expression in peripheral and central neuroectodermal tumors, other pediatric brain tumors, and during development of the adrenal gland.

Authors:  D L Baker; W M Molenaar; J Q Trojanowski; A E Evans; A H Ross; L B Rorke; R J Packer; V M Lee; D Pleasure
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

5.  Neurotrophin and neurotrophin receptor proteins in medulloblastomas and other primitive neuroectodermal tumors of the pediatric central nervous system.

Authors:  K Washiyama; Y Muragaki; L B Rorke; V M Lee; S C Feinstein; M J Radeke; D Blumberg; D R Kaplan; J Q Trojanowski
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

6.  Monoclonal antibodies to a rat nestin fusion protein recognize a 220-kDa polypeptide in subsets of fetal and adult human central nervous system neurons and in primitive neuroectodermal tumor cells.

Authors:  T Tohyama; V M Lee; L B Rorke; M Marvin; R D McKay; J Q Trojanowski
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

7.  Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma.

Authors:  R A Segal; L C Goumnerova; Y K Kwon; C D Stiles; S L Pomeroy
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

Review 8.  Growth factor receptors and medulloblastoma.

Authors:  L C Goumnerova
Journal:  J Neurooncol       Date:  1996-07       Impact factor: 4.130

9.  Chimeric tumor necrosis factor-TrkA receptors reveal that ligand-dependent activation of the TrkA tyrosine kinase is sufficient for differentiation and survival of PC12 cells.

Authors:  G Rovelli; R A Heller; M Canossa; E M Shooter
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

10.  Differential expression of nerve growth factor receptors leads to altered binding affinity and neurotrophin responsiveness.

Authors:  M Benedetti; A Levi; M V Chao
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.